The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
This SWHR webinar provides valuable insight for both patients and health care providers on opportunities to empower individuals living with endometriosis.
The Congressional Caucus on Black Women and Girls hosted a virtual event, supported by SWHR, raising awareness of the astounding impact of uterine fibroids on the health of women.
Join SWHR in celebrating achievements, advancements, & innovations in women’s health.
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
SWHR convened a working group of basic and clinical researchers, health care providers, patients/patient advocates, and policy leaders for a closed, two-day roundtable meeting to discuss the health, social, and economic impacts of alopecia, atopic dermatitis, and psoriatic arthritis on women.
SWHR hosted a virtual congressional briefing to raise awareness of policy needs to improve care for individuals with uterine fibroids, a condition that is underfunded and often overlooked in research.
SWHR convened an interdisciplinary working group for a closed roundtable meeting to discuss how to eliminate barriers to access and reduce health disparities related to genetic screening, with a focus on noninvasive prenatal screening (NIPS) and expanded carrier screening (ECS).
SWHR convened an interdisciplinary working group for a closed roundtable meeting to discuss how to eliminate barriers to access and reduce health disparities related to genetic screening, with a focus on noninvasive prenatal screening (NIPS) and expanded carrier screening (ECS).
SWHR convened an interdisciplinary working group for a closed roundtable meeting to discuss how to eliminate barriers to access and reduce health disparities related to genetic screening, with a focus on noninvasive prenatal screening (NIPS) and expanded carrier screening (ECS).
